How Has the Human Growth Hormone Market Evolved Historically and What is its Current Size?
The human growth hormone market has seen considerable growth due to a variety of factors.
• The human growth hormone market has grown rapidly in recent years. It will rise from $4.75 billion in 2024 to $5.23 billion in 2025, at a compound annual growth rate (CAGR) of 10.1%.
This growth is due to the increasing prevalence of growth disorders, heightened awareness of hormone therapies, expanded use in sports medicine, a growing geriatric population, and improvements in healthcare infrastructure.
What Is The Projected Growth Of The Human Growth Hormone Template Market?
The human growth hormone market is expected to maintain its strong growth trajectory in upcoming years.
• The human growth hormone market is expected to grow to $7.6 billion by 2029, with a CAGR of 9.8%.
This growth is driven by the rise of personalized medicine, increasing healthcare spending, the adoption of recombinant DNA technology, and the growing prevalence of endocrine disorders. Key trends include the expansion of distribution networks, AI integration in drug development, sustainable manufacturing, long-acting formulations, and combination therapies.
What Are The Key Drivers Fueling Growth In The Human Growth Hormone Market?
The growing awareness of treatment procedures is expected to propel the growth of the human growth hormone (HGH) market. As medical technologies advance and more information becomes available through digital media, awareness about treatments like HGH has increased. According to the National Survey on Drug Use and Health (NSDUH), the percentage of adolescents receiving mental health treatment rose significantly from 2021 to 2022, highlighting the growing public interest in medical interventions.
What Are The Principal Market Segments In The Global Human Growth Hormone Industry?
The human growth hormone market covered in this report is segmented –
1) By Product: Liquid, Powder
2) By Brand: Norditropin, Genotropin, Humatrope, Saizen, Omnitrope, Skytrofa, Others Brands
3) By Route Of Administration: Oral, Intravenous, Intramuscular, Subcutaneous
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacy, Specialty Pharmacy
5) By Application: Growth Hormone (GH) Deficiency, Adult Growth Hormone (GH) Deficiency, Pediatric Growth Hormone (GH) Deficiency, Turner Syndrome, Idiopathic Short Stature, Prader-Willi Syndrome, Small For Gestational Age, Other Applications
Subsegments:
1) By Liquid: Pre-Filled Liquid Syringes, Vials Of Liquid Growth Hormone
2) By Powder: Reconstitutable Powder, Freeze-Dried Powder
Pre-Book The Human Growth Hormone Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
What Emerging Trends Are Influencing The Growth Of The Human Growth Hormone Market?
Dominant players in the human growth hormone market like Pfizer Inc., and OPKO Health Inc. are intensifying their focus on the development and approval of drugs to progress their medical offerings and provide more effective treatments. The process of drug development is an intricate and stringent one, requiring several stages to validate the safety, efficacy, and quality of a new drug before it enters the market. For example, in June 2023, these two US-based biopharmaceutical firms announced that the Food and Drug Administration (FDA) had approved NGENLA (somatrogon-ghla). This treatment, which allows children with growth hormone deficiency to decrease the frequency of injections from daily to weekly, also promotes easier dosage administration and enhances patient compliance compared to daily injections. A Phase 3 study testified to NGENLA's non-inferiority to once-daily somatropin, and it was found to have a similar safety profile to somatropin, supporting the FDA approval.
Who Are the Key Players In The Human Growth Hormone Market?
Major companies operating in the human growth hormone market are:
• Pfizer Inc.
• Roche Holding AG
• Novartis AG
• Thermo Fisher Scientific Inc.
• Eli Lilly and Company
• Novo Nordisk A/S
• Merck KGaA
• Teva Pharmaceutical Industries Ltd.
• Sandoz International GmbH
• Ipsen Pharma
• Ferring Holding SA
• Endo International
• Zydus Lifesciences Limited
• Opko Health
• LG Life Sciences
• EMD Serono Inc.
• Wockhardt Ltd.
• JCR Pharmaceuticals Co. Ltd.
• Genentech Inc.
• Shanghai United Imaging Healthcare Co. Ltd.
• SOFAR S.p.A.
• United Laboratories
• Ascendis Pharma
• Uni-Pharma S.A.
• Versartis Inc.
• Reliance Life Sciences
• Anhui Anke Biotechnology (Group) Co. Ltd.
• Rani Therapeutics
What Are The Regional Insights Into The Human Growth Hormone Market?
North America was the largest region in the human growth hormone market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the human growth hormone market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
